The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?
- Written by Yaqoot Fatima, Professor of Sleep Health, University of the Sunshine Coast
coldsnowstorm/Getty ImagesLast week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.
The TGA has indicated Mounjaro can be used to treat moderate to severe obstructive sleep apnoea in adults with obesity (a...
Read more: The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?




